Recurrent lymphoma in a cardiac allograft recipient.
Johnson
F
F
Stanford University School of Medicine, Falk Cardiovascular Research Center, CA 94305-5246.
Hunt
S
S
D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014184:Transplantation, Homologous
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone